Nomograms for Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B Virus Infection

被引:220
|
作者
Yang, Hwai-I
Sherman, Morris
Su, Jun
Chen, Pei-Jer
Liaw, Yun-Fan
Iloeje, Uchenna H.
Chen, Chien-Jen [1 ]
机构
[1] Acad Sinica, Genom Res Ctr, Taipei 11529, Taiwan
关键词
LIVER FIBROSIS; BIOCHEMICAL MARKERS; HEART-DISEASE; PREDICTION; CIRRHOSIS; SCORE; PREVENTION; GENOTYPE; MODELS; LEVEL;
D O I
10.1200/JCO.2009.27.4456
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose Counseling patients with chronic hepatitis B virus (HBV) on their individual risk of liver disease progression is challenging. This study aimed to develop nomograms for predicting hepatocellular carcinoma risk in patients with chronic hepatitis B. Patients and Methods Two thirds of the Risk Evaluation of Viral Load Elevation and Associated Liver Disease/Cancer Hepatitis B Virus (REVEAL-HBV) study cohort was allocated for model derivation (n = 2,435), and the remaining third was allocated for model validation (n = 1,218). Previously confirmed independent risk predictors included in three Cox proportional hazards regression models were sex, age, family history of hepatocellular carcinoma, alcohol consumption habit, serum ALT level, hepatitis B envelope antigen (HBeAg) serostatus, serum HBV DNA level, and HBV genotype. Regression coefficients were rounded into integer risk scores, and predicted risk over 5- and 10-year periods for each risk score was calculated and depicted in nomograms. The predictive accuracy was evaluated using the area under the receiver operating characteristic curve (AUROC) and the correlation between predicted and observed hepatocellular carcinoma risk. Results All selected risk predictors were statistically significant in all models. In each model, either HBeAg seropositivity or HBeAg seronegativity with high viral load (HBV DNA level >= 100,000 copies/mL) and genotype C infection had the highest risk scores. All AUROCs for risk prediction nomogram were >= 0.82 in both model derivation and validation sets. The correlation coefficients between the observed hepatocellular carcinoma risk and the nomogram-predicted risk were greater than 0.90 in all model derivation and validation sets. Conclusion These easy-to-use nomograms based on noninvasive clinical characteristics can accurately predict the risk of hepatocellular carcinoma in patients with chronic hepatitis B. They may facilitate risk communication between patients and clinicians.
引用
收藏
页码:2437 / 2444
页数:8
相关论文
共 50 条
  • [41] Risk stratification for hepatitis B virus related hepatocellular carcinoma
    Lin, Chih-Lin
    Kao, Jia-Horng
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 (01) : 10 - 17
  • [42] Clinical significance of prior hepatitis B virus infection in patients with hepatitis C virus-related hepatocellular carcinoma
    Kubo, S
    Nishiguchi, S
    Hirohashi, K
    Tanaka, H
    Tsukamoto, T
    Hamba, H
    Shuto, T
    Yamamoto, T
    Ikebe, T
    Kinoshita, H
    CANCER, 1999, 86 (05) : 793 - 798
  • [43] Role of hepatitis D virus infection in development of hepatocellular carcinoma among chronic hepatitis B patients treated with nucleotide/nucleoside analogues
    Jang, Tyng-Yuan
    Wei, Yu-Ju
    Liu, Ta-Wei
    Yeh, Ming-Lun
    Liu, Shu-Fen
    Hsu, Cheng-Ting
    Hsu, Po-Yao
    Lin, Yi-Hung
    Liang, Po-Cheng
    Hsieh, Meng-Hsuan
    Ko, Yu-Min
    Tsai, Yi-Shan
    Chen, Kuan-Yu
    Lin, Ching-Chih
    Tsai, Pei-Chien
    Wang, Shu-Chi
    Huang, Ching-, I
    Lin, Zu-Yau
    Chen, Shinn-Cherng
    Chuang, Wan-Long
    Huang, Jee-Fu
    Dai, Chia-Yen
    Huang, Chung-Feng
    Yu, Ming-Lung
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [44] Does Antiviral Therapy for Chronic Hepatitis B Reduce the Risk of Hepatocellular Carcinoma?
    Abu-Amara, Mahmoud
    Feld, Jordan J.
    SEMINARS IN LIVER DISEASE, 2013, 33 (02) : 157 - 166
  • [45] Risk for hepatocellular carcinoma in the course of chronic hepatitis B virus infection and the protective effect of therapy with nucleos(t)ide analogues
    Rapti, Irene
    Hadziyannis, Stephanos
    WORLD JOURNAL OF HEPATOLOGY, 2015, 7 (08) : 1064 - 1073
  • [46] Application of Risk Scores for Hepatocellular Carcinoma in Patients with Chronic Hepatitis B: Current Status and Future Perspective
    Hsu, Yao-Chun
    Tseng, Cheng-Hao
    Huang, Yen-Tsung
    Yang, Hwai-, I
    SEMINARS IN LIVER DISEASE, 2021, 41 (03) : 285 - 297
  • [47] Risk for hepatocellular carcinoma in the course of chronic hepatitis B virus infection and the protective effect of therapy with nucleos(t)ide analogues
    Irene Rapti
    Stephanos Hadziyannis
    World Journal of Hepatology, 2015, 7 (08) : 1064 - 1073
  • [48] Incidence and natural history of hepatocellular carcinoma among patients with chronic infection with hepatitis C virus
    Ordóñez, FS
    Carrasco, JCG
    Recio, FJB
    Jiménez, AR
    Santos, PG
    López, TF
    REVISTA CLINICA ESPANOLA, 2000, 200 (07): : 360 - 366
  • [49] Prediction models of long-term Cirrhosis and hepatocellular carcinoma risk in chronic hepatitis B patients: Risk scores integrating host and virus profiles
    Lee, Mei-Hsuan
    Yang, Hwai-I.
    Liu, Jessica
    Batrla-Utermann, Richard
    Jen, Chin-Lan
    Iloeje, Uchenna H.
    Lu, Sheng-Nan
    You, San-Lin
    Wang, Li-Yu
    Chen, Chien-Jen
    HEPATOLOGY, 2013, 58 (02) : 546 - 554
  • [50] Hepatitis C virus infection as a major risk factor for hepatocellular carcinoma
    Caselmann, WH
    Alt, M
    JOURNAL OF HEPATOLOGY, 1996, 24 : 61 - 66